255 related articles for article (PubMed ID: 10730184)
1. [Letter DGS/DH dated November 18, 1999 on the treatment of paranesthetic malignant hyperthermia (MH)].
Couty E; Abenhaim L
Ann Fr Anesth Reanim; 2000 Feb; 19(2):Fi45-6. PubMed ID: 10730184
[No Abstract] [Full Text] [Related]
2. Malignant hyperthermia: a potentially fatal complication of anesthesia.
Stolworthy C; Haas RE
Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843
[TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia during a laparoscopic operation.
Watari A; Kobori H; Yamamoto T
J Minim Invasive Gynecol; 2011; 18(6):809-11. PubMed ID: 22024269
[TBL] [Abstract][Full Text] [Related]
4. [Malignant hyperthermia].
Bouhajja B; Haddad F; Ben Ammar MS
Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
[TBL] [Abstract][Full Text] [Related]
5. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
Patil PM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
[TBL] [Abstract][Full Text] [Related]
6. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
[TBL] [Abstract][Full Text] [Related]
7. Malignant hyperthermia.
Heggie J
Can J Anaesth; 1999 Sep; 46(9):910. PubMed ID: 10490170
[No Abstract] [Full Text] [Related]
8. [Dantrolene. Pharmacological and therapeutic aspects].
Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
[TBL] [Abstract][Full Text] [Related]
9. Mixing and using dantrolene for simulated malignant hyperthermia crisis.
Corvetto MA; Montaña R; Bravo MP; Altermatt FR
Acta Anaesthesiol Scand; 2012 Nov; 56(10):1337-8. PubMed ID: 22881345
[No Abstract] [Full Text] [Related]
10. Rapid intervention for an episode of malignant hyperthermia.
Chartrand D
Can J Anaesth; 2003 Feb; 50(2):104-7. PubMed ID: 12560297
[No Abstract] [Full Text] [Related]
11. Successful treatment of intraoperative malignant hyperthermia during renal transplantation.
Goss JA; Brennan DC; Miller BT; Shenoy S; McClure S; Howard TK; Flye MW
Clin Transplant; 1996 Apr; 10(2):195-8. PubMed ID: 8664518
[TBL] [Abstract][Full Text] [Related]
12. Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent.
Shukry M; Guruli ZV; Ramadhyani U
Paediatr Anaesth; 2006 Apr; 16(4):462-5. PubMed ID: 16618304
[TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia in a liver transplant patient: a case report.
Fernandes CR; Azevedo DM; Gomes JM; Gonçalves BP; Coelho GR; Vasconcelos JB; Garcia JH
Transplant Proc; 2007 Dec; 39(10):3530-2. PubMed ID: 18089429
[TBL] [Abstract][Full Text] [Related]
14. Postoperative hyperthermia of unknown origin treated with dantrolene sodium.
Inada H; Jinno S; Kohase H; Fukayama H; Umino M
Anesth Prog; 2005; 52(1):21-3. PubMed ID: 15859445
[TBL] [Abstract][Full Text] [Related]
15. Low-cost, easy-to-make simulated dantrolene for malignant hyperthermia scenarios.
Boet S
Acta Anaesthesiol Scand; 2014 Mar; 58(3):372-3. PubMed ID: 25237700
[No Abstract] [Full Text] [Related]
16. Dantrolene and heatstroke: a good molecule applied in an unsuitable situation.
Hausfater P
Crit Care; 2005 Feb; 9(1):23-4. PubMed ID: 15693976
[TBL] [Abstract][Full Text] [Related]
17. Recognizing and treating malignant hyperthermia.
Corvetto MA; Taekman JM
Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479
[No Abstract] [Full Text] [Related]
18. This looks like malignant hyperthermia!
Rivera PH; Worley C
J Post Anesth Nurs; 1995 Oct; 10(5):265-73; QUIZ 273-6. PubMed ID: 8632363
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia. It could happen to you.
Wraith A
SAAD Dig; 1996 Jul; 13(3):14-7. PubMed ID: 9477918
[No Abstract] [Full Text] [Related]
20. Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient.
Newmark JL; Voelkel M; Brandom BW; Wu J
Anesthesiology; 2007 Aug; 107(2):350-3. PubMed ID: 17667581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
